Lenalidomide enhances anti-myeloma cellular immunity

Lenalidomide is an effective therapeutic agent for multiple myeloma that exhibits immunomodulatory properties including the activation of T and NK cells. The use of lenalidomide to reverse tumor-mediated immune suppression and amplify myeloma-specific immunity is currently being explored. In the pre...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Luptakova, Katarina, Rosenblatt, Jacalyn, Glotzbecker, Brett, Mills, Heidi, Stroopinsky, Dina, Kufe, Turner, Vasir, Baldev, Arnason, Jon, Tzachanis, Dimitri, Zwicker, Jeffrey I., Joyce, Robin M., Levine, James D., Anderson, Kenneth C., Kufe, Donald, Avigan, David
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2012
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098790/
https://ncbi.nlm.nih.gov/pubmed/22733396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1308-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires